Cardiomyopathy Trial, Recruiting (NCT06661876)

Cardiomyopathy Trial, Recruiting NCT06661876 Sponsor: Universitaire Ziekenhuizen KU Leuven Condition: Cardiomyopathy

Printed from Voxsanity (voxsanity.com.au) — NCT06661876 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cardiomyopathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 or older
People with advanced heart failure that has not responded well to treatment, rated as Class II, III, or IV on a standard heart failure severity scale
People whose heart failure has been stable for the last 6 months and who are already on the maximum recommended heart failure medications
People whose heart failure is caused by blocked arteries (ischemic cardiomyopathy) or an enlarged, weakened heart (dilated cardiomyopathy)
People whose heart is pumping at 35% or less of its normal capacity, as measured by a heart scan
People who are able to sign a consent form and are willing to attend follow-up appointments

Who may not be able to join:

People who are currently being considered for or are eligible for a heart transplant
People who are pregnant or breastfeeding
People who have previously had radiotherapy that involved the heart area
People with any other medical condition that the trial doctors consider to be a reason not to participate (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +32 16 34 51 15

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06661876

Sponsor: Universitaire Ziekenhuizen KU Leuven

Phase: Not Applicable

Status: Recruiting

Condition: Cardiomyopathy

Trial contact: +32 16 34 51 15

More information: https://clinicaltrials.gov/study/NCT06661876

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 or older
People with advanced heart failure that has not responded well to treatment, rated as Class II, III, or IV on a standard heart failure severity scale
People whose heart failure has been stable for the last 6 months and who are already on the maximum recommended heart failure medications
People whose heart failure is caused by blocked arteries (ischemic cardiomyopathy) or an enlarged, weakened heart (dilated cardiomyopathy)
People whose heart is pumping at 35% or less of its normal capacity, as measured by a heart scan
People who are able to sign a consent form and are willing to attend follow-up appointments

Who may not be able to join:

People who are currently being considered for or are eligible for a heart transplant
People who are pregnant or breastfeeding
People who have previously had radiotherapy that involved the heart area
People with any other medical condition that the trial doctors consider to be a reason not to participate (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Universitaire Ziekenhuizen KU Leuven

Registry

ClinicalTrials.gov

Start date

1 January 2025

Est. completion

31 December 2026

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Change in left ventricular ejection fraction

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov